219 related articles for article (PubMed ID: 8770904)
1. Structural features of thyroid hormone response elements that increase susceptibility to inhibition by an RTH mutant thyroid hormone receptor.
Zavacki AM; Harney JW; Brent GA; Larsen PR
Endocrinology; 1996 Jul; 137(7):2833-41. PubMed ID: 8770904
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
Zavacki AM; Harney JW; Brent GA; Larsen PR
Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
[TBL] [Abstract][Full Text] [Related]
3. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
Ng L; Forrest D; Haugen BR; Wood WM; Curran T
Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
Piedrafita FJ; Ortiz MA; Pfahl M
Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
[TBL] [Abstract][Full Text] [Related]
5. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
[TBL] [Abstract][Full Text] [Related]
6. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor binds with unique properties to response elements that contain hexamer domains in an inverted palindrome arrangement.
Williams GR; Zavacki AM; Harney JW; Brent GA
Endocrinology; 1994 Apr; 134(4):1888-96. PubMed ID: 8137757
[TBL] [Abstract][Full Text] [Related]
9. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.
Kitajima K; Nagaya T; Jameson JL
Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470
[TBL] [Abstract][Full Text] [Related]
10. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain.
Nishiyama K; Andoh S; Kitahara A; Natsume H; Mikami T; Genma R; Nakamura H
Mol Cell Endocrinol; 1998 Mar; 138(1-2):95-104. PubMed ID: 9685218
[TBL] [Abstract][Full Text] [Related]
11. The function of retinoid X receptors on negative thyroid hormone response elements.
Takeda T; Nagasawa T; Miyamoto T; Hashizume K; DeGroot LJ
Mol Cell Endocrinol; 1997 Apr; 128(1-2):85-96. PubMed ID: 9140079
[TBL] [Abstract][Full Text] [Related]
12. Dominant-negative mutant thyroid hormone receptors prevent transcription from Xenopus thyroid hormone receptor beta gene promoter in response to thyroid hormone in Xenopus tadpoles in vivo.
Ulisse S; Esslemont G; Baker BS; Krishna V; Chatterjee K; Tata JR
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1205-9. PubMed ID: 8577741
[TBL] [Abstract][Full Text] [Related]
13. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
[TBL] [Abstract][Full Text] [Related]
14. Half-site arrangement of hybrid glucocorticoid and thyroid hormone response elements specifies thyroid hormone receptor complex binding to DNA and transcriptional activity.
Yen PM; Ikeda M; Wilcox EC; Brubaker JH; Spanjaard RA; Sugawara A; Chin WW
J Biol Chem; 1994 Apr; 269(17):12704-9. PubMed ID: 8175681
[TBL] [Abstract][Full Text] [Related]
15. Analysis of structure and expression of the Xenopus thyroid hormone receptor-beta gene to explain its autoinduction.
Machuca I; Esslemont G; Fairclough L; Tata JR
Mol Endocrinol; 1995 Jan; 9(1):96-107. PubMed ID: 7760854
[TBL] [Abstract][Full Text] [Related]
16. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
Takeda T; Suzuki S; Liu RT; DeGroot LJ
J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.
Zhu XG; McPhie P; Cheng SY
Endocrinology; 1997 Apr; 138(4):1456-63. PubMed ID: 9075702
[TBL] [Abstract][Full Text] [Related]
18. A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene.
Toyoda N; Zavacki AM; Maia AL; Harney JW; Larsen PR
Mol Cell Biol; 1995 Sep; 15(9):5100-12. PubMed ID: 7651427
[TBL] [Abstract][Full Text] [Related]
19. Roles of 3,5,3'-triiodothyronine and deoxyribonucleic acid binding on thyroid hormone receptor complex formation.
Yen PM; Brubaker JH; Apriletti JW; Baxter JD; Chin WW
Endocrinology; 1994 Mar; 134(3):1075-81. PubMed ID: 8119145
[TBL] [Abstract][Full Text] [Related]
20. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H
Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
